Branden Hsu MD in Katy, Texas

Home Texas Katy

Branden Hsu MD has Hematology/oncology as his primary medical specialty. Their primary office is: 1331 W Grand Pkwy N in Katy, Texas.

They're a part of the: Texas Oncology Pa medical group which has around 833 members. You can call their office at 281-392-2757 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Baylor College Of Medicine and graduated in 1997 (around 27 years of experience). They are listed as doing telehealth appointments.

Branden Hsu MD Office Phone and Directions

Branden Hsu MD
Texas Oncology Pa
1331 W Grand Pkwy N
Katy, Texas 77493
281-392-2757

Patient Ratings
Please rate your experience with Branden Hsu MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 281-392-2757

Enter a starting address:

Healthcare Info for Branden Hsu MD

Additional Medical Specialties Include:
MEDICAL ONCOLOGY

Medical School: Baylor College Of Medicine
Graduation Year: 1997
The Primary Medical Specialty for Branden Hsu MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 5496739450
NPI #: 1952342123
NPI Created On: 06/09/2006
NPI Last Updated Listed as: 07/28/2011
Primary Taxonomy Code: 207RH0003X
License Number:
K8916
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

FirstCare Health Plans
Humana
Community Health Choice
Molina Marketplace
Celtic Insurance Company
CHRISTUS Health Plan
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Microscopic examination for white blood cells with manual cell count
Complete blood cell count (red cells, white blood cell, platelets), automated test
Complete blood cell count (red cells, white blood cell, platelets), automated test
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Infusion of different chemotherapy drug or substance into a vein
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
Infusion of different chemotherapy drug or substance into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $340

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788853937

Being Disputed:: No

Product Related: No

Payments Total: $1,560

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788853933

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788853935

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $135

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Payment was made by a third party for participation in a market research study on behalf of GSK.

Record ID:: 802881771

Being Disputed:: No

Product Related: No

Payments Total: $2,750

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 803042839

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $1,225

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 832182939

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01

Payments Total: $1,250

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 832340239

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: TAZVERIK

Open Associated Drug #1: 72607-100-00

Payments Total: $1,700

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Context of payment:: ;KP26008;KPSCIM;10378991

Record ID:: 844415215

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CELLT

Name of Drug #1: Tecartus

Open Associated Drug #1: 71287-219-02

Payments Total: $1,140

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 843520581

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: SARCLISA

Open Associated Drug #1: 0024-0654-01

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: ;G2781670;EPRINTS;10378991

Record ID:: 845874257

Being Disputed:: No

Product Related: Yes

Hematology/oncology Professionals in Katy

1.
Srinath Sundararajan

1331 W Grand Pkwy N
Katy, TX
Texas Oncology Pa

2.
Gurjyot Doshi

1331 W Grand Pkwy N
Katy, TX
Texas Oncology Pa

3.
Ronjay Rakkhit MD

23960 Katy Fwy
Katy, TX
Oncology Consultants, P. A..

4.
Kathy Sam

23960 Katy Fwy
Katy, TX
Oncology Consultants, P. A..

Providers in Texas Oncology Pa

1.Mirna Abboud

501 W Medical Ctr Blvd
Webster Tx 77598-4219
Texas Oncology Pa
Radiation Oncology

2.Seyed Abedi

501 W Medical Ctr Blvd
Webster Tx 77598-4219
Texas Oncology Pa
Hematology/oncology

3.Seyed Abedi

1401 Medical Pkwy
Cedar Park Tx 78613-5026
Texas Oncology Pa
Hematology/oncology

4.Laith Abushahin

3705 W 15th St
Plano Tx 75075-7753
Texas Oncology Pa
Medical Oncology

5.Laith Abushahin

3410 Worth St
Dallas Tx 75246-2092
Texas Oncology Pa
Medical Oncology

6.Maria Acevedo

7848 Gateway Blvd E
El Paso Tx 79915-1815
Texas Oncology Pa
Nurse Practitioner

View all 833 members of Texas Oncology Pa medical group